FMO5 and chronic granulomatous disease: Additionally, ex vivo lentiviral gene transfer to autologous CD34+ hematopoietic stem and progenitor cells (HSPCs) is not well suited as a treatment for CGD, as proper physiological gene regulation of NADPH oxidase proteins has been shown to be required for hematopoietic stem cell function5.